Create account

Coverage dated August 19, 2026

Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market

Headline from Investor's Business Daily

The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion market for obesity drugs.

Investor's Business Daily's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

1 article, oldest first.

  1. Investor's Business Daily

    Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market (opens Investor's Business Daily)

    Published

    Investor's Business Daily's feed description

    The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion market for obesity drugs.